Search

everythinglearnresearchcommunity

for

Search:↓

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Removing a testosterone-producing tumor cured a woman's sleep apnea and other symptoms.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Hair loss in women may have causes other than hormones.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Lowering testosterone speeds up wound healing in male mice.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Acne is an important sign of androgen excess disorders in women.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Finasteride works better for hair loss in patients 26 or younger.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.